Experimental study on the preventive mechanism of salviae miltiorrhizae against atherosclerosis in rabbits models

Abstract

The preventive mechanism of salviae miltiorrhizae (SM) against experimental atherosclerosis (AS) in rabbits models was investigated. The experimental AS rabbit models were reproduced by feeding the high cholesterol diet. The changes of atherosclerotic plaques in normal group, model group and SM treated group were observed. The levels of serum TG, TC, HDL-C and LDL-C were determined. The immunohistochemistry was used to detect the expression of Bcl-2, Bax and IL-6 proteins in atherosclerotic plaques. The results showed that the level of serum TG in SM treated group was significantly lower than in model group (P<0.01). Immunohistochemistry revealed that the expression of Bcl-2, Bax and IL-6 in model group was significantly higher than in normal group. In the SM group, the expression of Bcl-2 protein was up-regulated and that of Bax was down-regulated. It was suggested that SM could inhibit formation of AS in experimental rabbits. To decrease the expression of Bax and increase the expression of Bcl-2 protein may be one of the mechanisms of SM against atherosclerosis.

Keywords

atherosclerosis / salviae miltiorrhizae / Bcl-2 / Bax

References

[1] MengZ H, ZhuF X, HanC L, et al. . The preventive Effect of Salvia Miltiorrhiza Bunge on Experimental Atherosclerosis. Cardiovasc Pulm Dis. (Chinese), 1995, 14(2): 101-101

[2] OltvaiZ N, MillimanC L, KorsmeyerS J. Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell, 1993, 74609-609

[3] HanadaM, Aime-SempecC, SatoT, et al. . Structure-function analysis of bel-2 protein: identification of conserved domains important for homo-dimerization with bcl-2 and heterodimerization with bax. J Biol Chem, 1995, 27011 962-11 962

[4] RinconM, AnguitaJ, NakamuraT, et al. . Interleukin (IL)-6 directs the differentiation of IL-4 producing CD4 +T cells. J Exp Med, 1997, 185461-461

[5] RidkerP M, RifaiN, StampferM J, et al. . Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation, 2000, 101(15): 1767-1767

[6] PradhanA D, MansonJ E, RifaiN, et al. . C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA, 2001, 286(3): 327-327

[7] WakefieldT W, GreenfieldL J, RolfeM W, et al. . Inflammatory and procoagulant mediator interactions in an experimental baboon model of venous thrombosis. Thromb Haemost, 1993, 169-69

[8] ZhangJ T, LiY Z, ZhaoS P. Study of RSM's neuroprotective effect and the expression of ICE and BCL-2 after ischemia and reprefusion. Stroke Nervous Dis (Chinese), 2001, 126-26

[9] ZhaoH L, WuX Y, LiZ Z, et al. . The effect of Salvia miltiorrhiza on the expression of Bcl-2 Bax and hepatosis in hepatic preservation and reperfusion. Chin J General Surg (Chinese), 2001, 16(10): 600-600

[10] MehtaU, KangB P, BansalG, et al. . Studies of apoptosis and bcl-2 in experimental atherosclerosis in rabbit and influence of selenium supplementation. Gen Physiol Biophys, 2002, 21(1): 15-15